Barry Callebaut AG : The underlying trend is to the upside
Entry price | Target | Stop-loss | Potential |
---|
CHF 2,258 |
CHF 2,450 |
CHF 2,140 |
+8.5% |
---|
Barry Callebaut AG shares show a positive technical situation which suggests a continuation of the upward dynamic over the medium term.
Summary● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
● The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths● Consensus analysts have strongly revised their opinion of the company over the past 12 months.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses● According to forecast, a sluggish sales growth is expected for the next fiscal years.
● The firm trades with high earnings multiples: 27.61 times its 2022 earnings per share.
● The company appears highly valued given the size of its balance sheet.
● The valuation of the company is particularly high given the cash flows generated by its activity.
● The company is not the most generous with respect to shareholders' compensation.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.